CGRP receptor antagonists
US11066386B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2018 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Jun 28, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula II or a pharmaceutically acceptable salts thereof, useful as a CGRP receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.